Liver Fibrosis Assay
Fibrosis
PreclinicalActive
Key Facts
About TissueVision
TissueVision is a private, revenue-generating contract research organization (CRO) focused on high-resolution 3D whole-tissue imaging and analysis. The company's core technology is its TissueCyte® imaging platform, which automates tissue sectioning and multi-spectral imaging to generate terabytes of quantitative data per study, enabling large-scale projects in neuroscience, oncology, and fibrosis. With a strong foundation from MIT and NIH grant support, TissueVision serves as a critical partner for clients needing scalable, statistically powerful histological data to advance therapeutic programs from discovery through preclinical development.
View full company profileTherapeutic Areas
Other Fibrosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Lead Fibrosis Program | Nosis Bio | Preclinical |
| OST-664 | Oncostellae | Discovery |
| NBA-1901 | NB Health Laboratory | Preclinical |
| Undisclosed second mAb | NB Health Laboratory | Preclinical |